Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Vascular occlusion
ADR ID BADD_A05286
ADR Hierarchy
24      Vascular disorders
24.04      Arteriosclerosis, stenosis, vascular insufficiency and necrosis
24.04.02      Non-site specific necrosis and vascular insufficiency NEC
24.04.02.015      Vascular occlusion
Description Not Available
MedDRA Code 10053648
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Occlusion | Occlusion NOS | Vascular occlusion
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00151Apixaban0.000530%
BADD_D00158Aprotinin (bovine)--
BADD_D00364Carboplatin0.000533%
BADD_D00568Dacarbazine--
BADD_D00589Dasatinib0.000533%
BADD_D00594Deferasirox0.008747%
BADD_D00787Epoetin alfa--
BADD_D00808Erythropoietin--
BADD_D01019Gianvi--
BADD_D01076Homatropine hydrobromide--
BADD_D01101Hydroxybutanedial--
BADD_D01253Lenalidomide0.002316%
BADD_D01336Macitentan0.000577%
BADD_D01376Melphalan0.000533%
BADD_D01506Muromonab-cd3--
BADD_D01567Nilotinib0.000799%
BADD_D01617Ondansetron--
BADD_D01618Ondansetron hydrochloride--
BADD_D01799Ponatinib--
BADD_D01800Ponatinib hydrochloride--
BADD_D01858Propagermanium--
BADD_D01954Rivaroxaban0.001249%
BADD_D01995Scopolamine hydrobromide--
BADD_D02170Testosterone0.000594%
BADD_D02214Ticagrelor0.004405%
BADD_D02268Treprostinil0.000742%
BADD_D02354Vidarabine monohydrate--
BADD_D02373Warfarin0.000240%
The 1th Page    1    Total 1 Pages